Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA (2007) Cell Host Microbe 2: 240-9 Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Wanzeck K, Boyd KL, McCullers JA (2011) Am J Respir Crit Care Med 183: 767-73 CD154 regulates primate humoral immunity to influenza. Crowe JE, Sannella EC, Pfeiffer S, Zorn GL, Azimzadeh A, Newman R, Miller GG, Pierson RN (2003) Am J Transplant 3: 680-8 Unveiling the burden of influenza-associated pneumococcal pneumonia. Grijalva CG, Griffin MR (2012) J Infect Dis 205: 355-7 Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B (2010) J Infect Dis 202: 1287-95 Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. Karlström A, Boyd KL, English BK, McCullers JA (2009) J Infect Dis 199: 311-9 Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. Karlström A, Heston SM, Boyd KL, Tuomanen EI, McCullers JA (2011) J Infect Dis 204: 1358-66 CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. Assarsson E, Kambayashi T, Sandberg JK, Hong S, Taniguchi M, Van Kaer L, Ljunggren HG, Chambers BJ (2000) J Immunol 165: 3673-9 Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE (2010) J Virol 84: 3127-30 A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, Crowe JE (2011) J Virol 85: 10905-8 Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Albrecht R, Blum DL, Ramos I, Fernandez-Sesma A, Edwards KM, García-Sastre A, Basler CF, Crowe JE (2012) J Virol 86: 6334-40 Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice. Hooper KA, Crowe JE, Bloom JD (2015) J Virol 89: 3737-45 Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. Alymova IV, Green AM, van de Velde N, McAuley JL, Boyd KL, Ghoneim HE, McCullers JA (2011) J Virol 85: 12324-33 Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA (2006) Infect Immun 74: 2562-7 The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Samarasinghe AE, Woolard SN, Boyd KL, Hoselton SA, Schuh JM, McCullers JA (2014) Immunol Cell Biol 92: 449-59 A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase. Hayakawa M, Toda N, Carrillo N, Thornburg NJ, Crowe JE, Barbas CF (2012) Chembiochem 13: 2191-5 Seroprevalence of seasonal and pandemic influenza A viruses in domestic cats. McCullers JA, Van De Velde LA, Schultz RD, Mitchell CG, Halford CR, Boyd KL, Schultz-Cherry S (2011) Arch Virol 156: 117-20 Chloroquine is effective against influenza A virus in vitro but not in vivo. Vigerust DJ, McCullers JA (2007) Influenza Other Respir Viruses 1: 189-92
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.